AstraZeneca
in amyloidosis | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
38 of 49
Related slides by other companies
MindMed
Investor Presentation
November 2024
for gad phase study designs voyage panorama | MindMed
Recursion Pharmaceuticals
Investor Day
January 2023
clinical phase trial initiated in enrollment criteria outcome measures trial update tupelo for underway | Recursion Pharmaceuticals
DICE Therapeutics
Results
March 2023
disposition of psoriasis patients in pic nice paar paints vee | DICE Therapeutics
MindMed
Investor Presentation
January 2025
for phase study design design | MindMed
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights